Literature DB >> 1856821

Kaposi's sarcoma in a patient with rheumatoid arthritis possible responsibility of captopril in the development of lesions.

J P Larbre1, J F Nicolas, P Collet, B Larbre, G Llorca.   

Abstract

Kaposi's sarcoma appeared 8 months after the start of captopril treatment in a 70-year-old woman with rheumatoid arthritis. A marked reduction of cutaneous and gastric lesions occurred when captopril was stopped. These findings are compared to immunosuppressive drug induced forms of Kaposi's sarcoma.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1856821

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Rheumatoid arthritis, corticosteroid therapy and Kaposi's sarcoma: a coincidence? A case and review of literature.

Authors:  P Casoli; B Tumiati
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

2.  Multifactorial etiology of Kaposi' sarcoma: a hypothesis.

Authors:  Harry W Haverkos
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

Review 3.  Carcinogenicity of antihypertensive therapy.

Authors:  Ehud Grossman; Franz H Messerli; Uri Goldbourt
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

4.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

Review 5.  Carcinogenicity of cardiovascular drugs.

Authors:  E Grossman; F H Messerli; U Goldbourt
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

6.  Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma.

Authors:  W X Guo; T Antakly; M Cadotte; Z Kachra; L Kunkel; R Masood; P Gill
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

Review 7.  Antihypertensive therapy and cancer risk.

Authors:  D C Felmeden; G Y Lip
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

8.  Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide.

Authors:  Sang Yeob Lee; Yong Min Jo; Won Tae Chung; Sung Hyun Kim; Seung Young Kim; Mee Sook Roh; Sung Won Lee
Journal:  Rheumatol Int       Date:  2010-01-10       Impact factor: 3.580

Review 9.  Angiotensin-converting enzyme inhibitors side effects--physiologic and non-physiologic considerations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-07       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.